AAC
n my last article, I described the unique approach of the governments of Arkansas, including counties, cit- ies, and the state, in the united lawsuit that has been filed against opioid manufacturers, distributors, and criminally-convicted pharmacies and healthcare profession- als, in the hope of obtaining a comprehensive remedy to the Arkansas Opioid Epidemic. Tis quarter, I will provide an update about what has happened and is happening since the complaint was filed in March, and what we expect as we move forward with this unprecedented case. First, we are pleased to report that the lawsuit remains on file with the Crittenden County Circuit Court. Te defendants and their (over 100) attorneys have not “removed” the case to federal court, and we do not believe they have a good-faith ba- sis to do so. With each passing day, we come closer to realizing the goal of a jury trial in Arkansas, with an Arkansas judge and Arkansas jurors. Second, as we have learned more about some of the defen- dants through their filings and through communications with counsel, we have “nonsuited” (dismissed) a few defendants who have shown that they did not and do not manufacture or sell or market Schedule II opioids in Arkansas. We expect that as the case moves forward, as we access the defendants’ information and other data about opioids in Arkansas, we will continue to learn more about the individuals and entities re- sponsible for the Arkansas Opioid Epidemic. Te makeup of the defendants may change with potential addition and sub- traction of defendants based on that information. Tird, the original presiding judge — Crittenden County
I
Circuit Judge Richard Lusby — recused on Aug. 1. Te case has been reassigned to Crittenden County Circuit Judge Pam Honeycutt. Fourth, at the end of June, most of the defendant opioid manufacturers and distributors filed motions and legal memo- randums totaling nearly 2,000 pages in which they asked the court to dismiss the government’s lawsuit against them. Tis was expected, and it was also unsurprising to see so many mo- tions and briefs filed at the same time. Together, the filings by the defendants covered topics and arguments about personal jurisdiction, fact-pleading standards, venue, preemption, stat- utes of limitations, causation and injury, several common-law doctrines, standing, punitive damages, and the merits of the claims brought by the counties, cities, and state under Arkan- sas law. Did I mention that the defendants filed nearly 2,000 pages of paper? On Aug. 30, we filed a unified (“omnibus”) response to all the defendants’ motions, on behalf of all the government plain- tiffs. We responded to every argument, and we defended the validity of all the claims asserted in the complaint against the drug companies allegedly responsible for the Arkansas Opioid
22
LITIGATION LESSONS Opioid litigation update
Epidemic — and we did so in less than 100 pages. Te position we ad- vocate is that under the facts alleged in the complaint, the plaintiff coun- ties, cities, and state should be per- mitted to pursue all claims asserted against the defendants: negligence, common-law public nuisance, claims under the Arkansas Civil Action by Crime Victims statute, including the Arkansas Uniform Narcotic Drug Act and the Arkansas Controlled Substances Act, and claims under the Arkansas Drug Dealer Liability Act. On the same day that we filed the omnibus response (Aug.
Colin Jorgensen Risk Management Litigation Counsel
30), we sent a detailed letter to the federal Drug Enforcement Administration (DEA) in which we requested access to in- formation from the DEA’s “ARCOS” database, which tracks opioid sales nationwide throughout the supply chain, from manufacturer to final sale. Tis evidence could be critical to the governments’ claims against the drug companies involved in the supply chain. We have properly offered to work with the DEA to craft a protective order governing use of the ARCOS data for this litigation and law enforcement, while otherwise maintaining the confidentiality of the ARCOS data. Moving forward, we expect the defendants to file a reply (or a barrage of individual replies or both) by their deadline in early October. After that, the defendants’ motions will be ripe for a ruling by the court. We expect the court to schedule a hearing for argument on the motions sometime after the com- pletion of briefing. Meanwhile, we intend to pursue the AR- COS data from the DEA and discovery from the defendants and begin working to craft remedies for the Arkansas Opioid Epidemic. We intend to prosecute this case, and there is much work to be done. We see no reason to pause for resolution of defense motions that we believe are meritless and should be summarily denied. Aug. 31, 2018 — the day after we filed the omnibus brief — was International Opioid Awareness Day. A commemora- tive event was organized by State Drug Director Kirk Lane at the State Capitol that from 6:30 p.m. to 8 p.m. that Friday. Just before 6:30 p.m. there was a brief rain shower, and at pre- cisely 6:30 p.m., a double rainbow appeared in the downtown landscape, blanketing the view from the Capitol steps. Di- rector Lane, KTHV-TV Reporter Laura Monteverde, Trevor Villines, and others, including multiple addicts in recovery, gave compelling speeches about overdose and recovery, about battles won and lost, and about battles that lie ahead. Te event was a powerful reminder of what this case is all about. Of course, we don’t need a reminder.
COUNTY LINES, SUMMER 2018
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
